The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Open accessAbstract
BACKGROUND: Mesenchymal stromal cells (MSCs, "adult stem cells") have been widely used experimentally in a variety of clinical contexts. There is interest in using these cells in critical illness, however, the safety profile of these cells is not well known. We thus conducted a systematic review of clinical trials that examined the use MSCs to evaluate their safety. METHODS AND FINDINGS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (to June 2011), were searched. Prospective clinical trials that used intravascular delivery of MSCs (intravenously or intra-arterially) in adult populations or mixed adult and pediatric populations were identified. Studies using differentiated MSCs or additional cell types were excluded. The primary outcome adverse events were grouped according to immediate events (acute infusional toxicity, fever), organ system complications, infection, and longer term adverse events (death, malignancy). 2347 citations were reviewed and 36 studies met inclusion criteria. A total of 1012 participants with clinical conditions of ischemic stroke, Crohn's disease, cardiomyopathy, myocardial infarction, graft versus host disease, and healthy volunteers were included. Eight studies were randomized control trials (RCTs) and enrolled 321 participants. Meta-analysis of the RCTs did not detect an association between acute infusional toxicity, organ system complications, infection, death or malignancy. There was a significant association between MSCs and transient fever. CONCLUSIONS: Based on the current clinical trials, MSC therapy appears safe. However, further larger scale controlled clinical trials with rigorous reporting of adverse events are required to further define the safety profile of MSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., & Keiliss-Borok, I. V. (1974) · Transplantation · doi:10.1097/00007890-197404000-00001 · Cited by 1,431
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.055 · Cited by 1,350
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166 · cited 1×
“[47] Although recent position papers have suggested low probability of malignant transformation and tumour formation with MSCs, [7] our review is the first systematic analysis of the issue.”
BackgroundMesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
Why are MSCs therapeutic? New data: new insight
Caplan, A. (2009) · The Journal of Pathology · doi:10.1002/path.2469 · Cited by 1,114
Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J. M., Kassis, I., Bulte, J. W. M., Petrou, P., Ben-Hur, T., Abramsky, O., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.248 · Cited by 941
Lazarus, H. M., Koc, O. N., Devine, S. M., Curtin, P., Maziarz, R. T., Holland, H. K., Shpall, E. J., McCarthy, P., Atkinson, K., Cooper, B. W., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.02.001 · Cited by 803
Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., & Bang, O. Y. (2010) · Stem Cells · doi:10.1002/stem.430 · Cited by 779
Lazarus, H. M., Haynesworth, S. E., Gerson, S. L., Rosenthal, N. S., & Caplan, A. I. (1995) · PubMed · Cited by 749
Mei, S. H. J., Haitsma, J. J., Dos Santos, C. C., Deng, Y., Lai, P. F. H., Slutsky, A. S., Liles, W. C., & Stewart, D. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0010oc · Cited by 721
Self-citationKoç, O., Day, J., Nieder, M., Gerson, S., Lazarus, H., & Krivit, W. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703650 · Cited by 652
Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622 · cited 14×
“Liang et al, 2011 [36] N N Infusional toxicity+ N Fever+ Organ dysfunction (GI, disease relapse)+ Duijvestein et al, 2010 [30] Y N Infusional toxicity (DMSO allergic reaction, DMSO taste/smell, headache)+ limited Fever+ Organ dysfunction (gastrointestinal– nausea,vomiting, diarrhea, anorexia,…”
BackgroundMethodResultInfluentialMei, S. H. J., McCarter, S. D., Deng, Y., Parker, C. H., Liles, W. C., & Stewart, D. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040269 · Cited by 619
Self-citationSun, L., Akiyama, K., Zhang, H., Yamaza, T., Hou, Y., Zhao, S., Xu, T., Le, A., & Shi, S. (2009) · Stem Cells · doi:10.1002/stem.68 · Cited by 580
Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S.-C., Smith, J., & Prockop, D. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.012 · Cited by 509
Shahdadfar, A., Frønsdal, K., Haug, T., Reinholt, F. P., & Brinchmann, J. E. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0094 · Cited by 501
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke
Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S. G., & Kocsis, J. D. (2011) · Brain · doi:10.1093/brain/awr063 · Cited by 494
Sun, L., Wang, D., Liang, J., Zhang, H., Feng, X., Wang, H., Hua, B., Liu, B., Ye, S., Hu, X., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27548 · Cited by 475
Liang, J., Zhang, H., Hua, B., Wang, H., Lu, L., Shi, S., Hou, Y., Zeng, X., Gilkeson, G. S., & Sun, L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123463 · Cited by 449
Kebriaei, P., Isola, L., Bahceci, E., Holland, K., Rowley, S., McGuirk, J., Devetten, M., Jansen, J., Herzig, R., Schuster, M., et al. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.012 · Cited by 437
Noninfectious Serious Hazards of Transfusion
Hendrickson, J. E., & Hillyer, C. D. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181930a6e · Cited by 419
Ning, H., Yang, F., Jiang, M., Hu, L., Feng, K., Zhang, J., Yu, Z., Li, B., Xu, C., Li, Y., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405090 · Cited by 407
Defining the risks of mesenchymal stromal cell therapy
Prockop, D. J., Brenner, M., Fibbe, W. E., Horwitz, E., Le Blanc, K., Phinney, D. G., Simmons, P. J., Sensebe, L., & Keating, A. (2010) · Cytotherapy · doi:10.3109/14653249.2010.507330 · Cited by 339
Alimoghaddam, K., Mohamadnejad, M., Mohyedin Bonab, M., Bagheri, M., Bashtar, M., Ghanati, H., Ghavamzadeh, A., & Malekzadeh, R. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.12.115 · Cited by 270
Mohamadnejad, M., Alimoghaddam, K., Mohyeddin‐Bonab, M., Bagheri, M., Bashtar, M., Ghanaati, H., Baharvand, H., Ghavamzadeh, A., & Malekzadeh, R. (2007) · PubMed · Cited by 258
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
Weng, J. Y., Du, X., Geng, S. X., Peng, Y. W., Wang, Z., Lu, Z. S., Wu, S. J., Luo, C. W., Guo, R., Ling, W., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.195 · Cited by 240
Fang, B., Song, Y., Liao, L., Zhang, Y., & Zhao, R. C. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.08.103 · Cited by 238
Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., Lejeune, M., Gothot, A., et al. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.01.011 · Cited by 229
Lee, P., Kim, J., Bang, O., Ahn, Y., Joo, I., & Huh, K. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100386 · Cited by 217
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres
Windrum, P., Morris, T. C. M., Drake, M. B., Niederwieser, D., Ruutu, T., & Subcommittee, O. B. O. T. E. C. L. W. P. C. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705100 · Cited by 216
CHIN, B. B., NAKAMOTO, Y., BULTE, J. W., PITTENGER, M. F., WAHL, R., & KRAITCHMAN, D. L. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200311000-00005 · Cited by 210
Ringdén, O., Uzunel, M., Sundberg, B., Lönnies, L., Nava, S., Gustafsson, J., Henningsohn, L., & Le Blanc, K. (2007) · Leukemia · doi:10.1038/sj.leu.2404833 · Cited by 208
Mesenchymal stem cells for acute lung injury: Preclinical evidence
Matthay, M. A., Goolaerts, A., Howard, J. P., & Woo Lee, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f1ff1d · Cited by 178
Chen, S., Wu-wang, F., Qian, J., et al. (2004) · PubMed · Cited by 163
Zhang, Z.-X., Guan, L., Zhang, K., Zhang, Q., & Dai, L. (2008) · Cytotherapy · doi:10.1080/14653240701883061 · Cited by 151
Gonzalo‐Daganzo, R. M., Regidor, C., Martín-Donaire, T., Rico, M. Á., Bautista, G., Krsnik, I., Forés, R., Ojeda, E., Sanjuán, I., Garcia-Marco, J. A., et al. (2009) · Cytotherapy · doi:10.1080/14653240902807018 · Cited by 145
Liang, J., Zhang, H., Wang, D., Feng, X., Wang, H., Hua, B., Liu, B., & Sun, L. (2011) · Gut · doi:10.1136/gutjnl-2011-300083 · Cited by 132
Mesenchymal Stem Cell Therapy for Cardiac Repair
Boyle, A., McNiece, I., & Hare, J. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-705-1_5 · Cited by 102
Meuleman, N., Tondreau, T., Ahmad, I., Kwan, J., Crokaert, F., Delforge, A., Dorval, C., Martiat, P., Lewalle, P., Lagneaux, L., et al. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0029 · Cited by 94
Wang, D., Zhang, H., Cao, M., Tang, Y., Liang, J., Feng, X., Wang, H., Hua, B., Liu, B., & Sun, L. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141804 · Cited by 84
Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.
Mohyeddin‐Bonab, M., Mohamad-Hassani, M.-R., Alimoghaddam, K., Sanatkar, M., Gasemi, M., Mirkhani, H., Radmehr, H., Salehi, M., Eslami, M., Farhig-Parsa, A., et al. (2007) · PubMed · Cited by 81
Liu, L., Sun, Z., Chen, B., Han, Q., Liao, L., Jia, M., Cao, Y., Ma, J., Sun, Q., Guo, M., et al. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.349 · Cited by 67
Arima, N., Nakamura, F., Fukunaga, A., Hirata, H., Machida, H., Kouno, S., & Ohgushi, H. (2009) · Cytotherapy · doi:10.3109/14653240903390795 · Cited by 65
Vanikar, A. V., Trivedi, H. L., Feroze, A., Kanodia, K. V., Dave, S. D., & Shah, P. R. (2010) · International Urology and Nephrology · doi:10.1007/s11255-009-9659-1 · Cited by 38
Frère, P., Baron, F., Bonnet, C. M., Hafraoui, K., Pereira, M., Willems, E., Fillet, G., & Beguin, Y. P. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705255 · Cited by 37
The Future of Clinical Trials Evaluating Blood Substitutes
Fergusson, D. A., & McIntyre, L. (2008) · JAMA · doi:10.1001/jama.299.19.jed80027 · Cited by 33
Self-citationThe value of meta-analysis in rheumatology research.
Ioannidis, J. P. A. (2004) · PubMed · Cited by 5
Research works printed but not linked: 7
- (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5, The Cochrane Library. In: Higgins JPT, Green S, editors. Chichester, UK: John Wiley & Sons, Ltd.
- S Chen, 2006, Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery, J Invasive Cardiol, 18, 552
- JA Wang, 2006, [A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy], Zhonghua Xin Xue Guan Bing Za Zhi, 34, 107
- ZW Xie, 2007, Curative effect of autologous mesenchymal stem cell transplantation on spinal cord injury. [Chinese], Journal of Clinical Rehabilitative Tissue Engineering Research, 11, 1277
- Z Yang, 2010, A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery, Cardiovasc Ther, 28, 380, 10.1111/j.1755-5922.2009.00116.x · doi:10.1111/j.1755-5922.2009.00116.x
- X Zhang, 2010, Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases, Int J Lab Hematol, 32, 256, 10.1111/j.1751-553X.2009.01181.x · doi:10.1111/j.1751-553x.2009.01181.x
- R Syme, 2004, The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity, Biol Blood Marrow Transplant, 10, 135, 10.1016/j.bbmt.2003.09.016 · doi:10.1016/j.bbmt.2003.09.016
Cited by
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
Mesenchymal stem cells: immune evasive, not immune privileged
Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2816 · Cited by 1,531
Clinical Trials with Mesenchymal Stem Cells: An Update
Squillaro, T., Peluso, G., & Galderisi, U. (2016) · Cell Transplantation · doi:10.3727/096368915x689622 · Cited by 1,395
Extracellular vesicles as drug delivery systems: Why and how?
Elsharkasy, O. M., Nordin, J. Z., Hagey, D. W., de Jong, O. G., Schiffelers, R. M., Andaloussi, S. E., & Vader, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.004 · Cited by 1,197
Mesenchymal Stem Cells for Regenerative Medicine
Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., & Ding, J. (2019) · Cells · doi:10.3390/cells8080886 · Cited by 1,093
Metadata
- Authors
- Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J., & Canadian Critical Care Trials Group
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-25
- Volume
- 7
- Issue
- 10
- Pages
- e47559
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2031790029
- Cited by
- 1,146
- References
- 51
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.